UK In Major Move To Boost Commercial Clinical Trials & Improve Life Sciences Environment
Executive Summary
The publication of two major reports has led the UK government to announce a £650m “Life Sci for Growth” package to bolster the life sciences sector.
You may also be interested in...
UK To Combat Clinical Trial Issues With Upstream Support For Sponsors & International Collaboration
The UK medicines regulator is mulling the possibility of drawing on its existing international regulatory partnerships, such as the ACCESS Consortium, to tackle challenges in its clinical trials sector, and says sponsors can expect greater support early in the trial process.
UK Held Back By ‘Painfully Slow’ NHS Decision-Making, Uncompetitive Drug Pricing
A panel of experts has outlined several areas for improvement in the UK’s life sciences ecosystem in light of a report by Sanofi that supports claims that the UK is lagging behind EU competitors in its delivery of innovative medicines to patients.
UK Aims To Quadruple Patient Recruitment To Industry Clinical Trials By 2027
The UK government has set aside dedicated funds to deliver ambitious changes that would make it quicker and easier for companies to trial more of their products in the National Health Service.